National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Featured Clinical Trials

Cancer Studies Highlighted in the NCI Cancer Bulletin
< Back to Main

Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Search by Cancer Type
Breast Cancer

Colon and Rectal Cancer

Lung Cancer

Prostate Cancer

More Featured Trials
Search Featured Trials

    Search  
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Restructuring the NCI Clinical Trials Enterprise

Clinical Trials Reporting Program

Coordinating Center for Clinical Trials

States Requiring Coverage of Clinical Trial Costs
You CAN Quit Smoking Now!
Related Pages
Search for Clinical Trials
NCI's PDQ® Cancer Clinical Trials Registry.

Bone Cancer Home Page
NCI's gateway for information about bone cancer.
Bone Cancer - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

1.  Studying Dyskeratosis Congenita
(Posted: 07/11/2006) - Persons with a rare disorder called dyskeratosis congenita (DC) tend to have a high risk of developing bone marrow failure, leukemia, or certain carcinomas. NCI is undertaking an intensive assessment of families with DC to learn more about how genes associated with it lead to cancer development and to identify new susceptibility genes for DC.

2.  Study of Cancer Susceptibility Among Patients with Inherited Bone Marrow Failure Syndromes
(Posted: 06/29/2004) - Persons with inherited bone marrow failure syndromes (IBMFS) tend to have a very high risk of developing certain cancers. Researchers are assembling a study population that includes IBMFS patients and their family members.

3.  Familial Chordoma Study
(Posted: 05/11/2004) - Some people may be genetically predisposed to develop chordoma, a rare bone tumor. Because genetic or hereditary risk factors for chordoma may exist, scientists are searching for genes involved in the development of this tumor.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov